The increasing demand for hormone therapy, particularly estrogen patches, has led to significant shortages, leaving many women struggling to refill their prescriptions. In areas like Greater Boston and British Columbia, patients are facing long waits and searching for alternative options. Supply chain issues have been exacerbating this problem, prompting concerns among healthcare providers and patients alike. The FDA has removed outdated warning labels from menopause hormone replacement therapies, signaling a shift in regulatory approach amidst the current shortage. Women affected by the estrogen patch scarcity are encouraged to consult their doctors for alternative treatment options.